Aflac (NYSE:AFL) EVP Steven Kent Beaver Sells 7,387 Shares

Aflac Incorporated (NYSE:AFL) EVP Steven Kent Beaver sold 7,387 shares of the firm’s stock in a transaction on Friday, February 20th. The stock was sold at an average price of $113.58, for a total value of $839,015.46. Following the completion of the transaction, the executive vice president directly owned 40,526 shares of the company’s stock, valued at approximately $4,602,943.08. This trade represents a 15.42% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link.

Steven Kent Beaver also recently made the following trade(s):

• On Friday, December 12th, Steven Kent Beaver sold 5,492 shares of Aflac stock. The shares were sold at an average price of $109.53, for a total transaction of $601,538.76.
• On Friday, December 5th, Steven Kent Beaver sold 3,452 shares of Aflac stock. The stock was sold at an average price of $109.26, for a total transaction of $377,165.52.

Aflac Price Performance

Shares of Aflac stock traded up $0.13 during trading on Tuesday, hitting $112.48. 1,678,037 shares of the company’s stock traded hands, compared to its average volume of 2,322,685. The company has a market cap of $58.95 billion, a PE ratio of 16.35, a PEG ratio of 3.73 and a beta of 0.67. The firm’s fifty day moving average price is $111.31 and its 200 day moving average price is $109.81. Aflac Incorporated has a twelve month low of $96.95 and a twelve month high of $119.32. The company has a debt-to-equity ratio of 0.29, a current ratio of 0.11 and a quick ratio of 0.11.

Aflac (NYSE:AFL) last announced its quarterly earnings results on Wednesday, February 4th. The financial services provider reported $1.57 EPS for the quarter, missing analysts’ consensus estimates of $1.69 by ($0.12). Aflac had a return on equity of 14.35% and a net margin of 21.24%.The business had revenue of $4.87 billion for the quarter, compared to the consensus estimate of $4.45 billion. During the same quarter in the prior year, the business earned $1.57 EPS. The firm’s revenue for the quarter was down 9.6% on a year-over-year basis. Analysts forecast that Aflac Incorporated will post 6.88 earnings per share for the current year.

Institutional Investors Weigh In On Aflac

Several institutional investors have recently modified their holdings of the business. Astoria Portfolio Advisors LLC. lifted its holdings in Aflac by 10.2% in the fourth quarter. Astoria Portfolio Advisors LLC. now owns 3,814 shares of the financial services provider’s stock valued at $429,000 after buying an additional 353 shares during the period. Pacer Advisors Inc. boosted its position in shares of Aflac by 16.2% in the 4th quarter. Pacer Advisors Inc. now owns 45,045 shares of the financial services provider’s stock worth $4,967,000 after purchasing an additional 6,295 shares during the last quarter. Kera Capital Partners Inc. acquired a new stake in shares of Aflac during the fourth quarter worth $264,000. MV Capital Management Inc. acquired a new stake in shares of Aflac during the fourth quarter worth $470,000. Finally, Compound Planning Inc. lifted its stake in Aflac by 2.6% in the fourth quarter. Compound Planning Inc. now owns 13,652 shares of the financial services provider’s stock valued at $1,505,000 after buying an additional 347 shares during the period. Institutional investors and hedge funds own 67.44% of the company’s stock.

Analysts Set New Price Targets

A number of research analysts have issued reports on the company. JPMorgan Chase & Co. lifted their price objective on Aflac from $101.00 to $105.00 and gave the company a “neutral” rating in a report on Monday, January 5th. Wells Fargo & Company lifted their price target on shares of Aflac from $107.00 to $109.00 and gave the company an “equal weight” rating in a report on Friday, November 7th. Raymond James Financial reaffirmed an “outperform” rating and set a $119.00 price objective (up from $110.00) on shares of Aflac in a research note on Tuesday, December 30th. Barclays set a $101.00 target price on Aflac and gave the stock an “underweight” rating in a report on Thursday, January 8th. Finally, Morgan Stanley set a $120.00 price target on Aflac in a report on Monday, December 15th. Three equities research analysts have rated the stock with a Buy rating, six have given a Hold rating and three have issued a Sell rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average price target of $110.91.

Aflac Company Profile

Aflac Incorporated (American Family Life Assurance Company of Columbus) is a provider of supplemental insurance products designed to help policyholders manage out-of-pocket health care and living expenses. The company underwrites a range of individual and group policies that typically pay cash benefits directly to insureds when covered events occur, enabling greater financial flexibility for medical treatment, hospital stays, critical illness, and related costs. Aflac’s product mix includes supplemental health insurance, life insurance and other specialty coverages intended to complement primary medical plans.

Founded in the mid-20th century and headquartered in Columbus, Georgia, Aflac distributes its products through a combination of employer-sponsored programs, independent brokers and agents, and direct marketing.